Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting Nrip1 to alleviate metabolic disease

Targeting Nrip1 to alleviate metabolic disease

US Patent 12031161 · Granted Jul 9, 2024

Estimated economic value: $1,071,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Complexes for gene deletion and editing2022
Human adipose tissue white and ‘brown-on-white’ progenitors for reconstructive a2021
Human adipose tissue white and ‘brown-on-white’ progenitors for reconstructive a2018
Glucan-encapsulated siRNA for treating type 2 diabetes mellitus2018
Compositions and methods for inducing myoblast differentiation and myotube forma2016
Compositions and methods for decreasing leukocyte extravasation and vessel fluid2016
Pyridopyrazine derivatives and their use2015
RIP140 regulation of glucose transport2013
Quinoxaline derivatives and their use for treating benign and malignant tumour d2013
Encapsulated nanoparticles for nucleic acid delivery2013
Increasing glucose transport and insulin-stimulated glucose uptake2013
Pyridopyrazines and their use as modulators of kinases2012